Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 6/20 | 0.66 |
| ▸ | CCKBR | P32239 | 4/20 | 0.66 |
| ▸ | CALCR | P30988 | 4/20 | 0.61 |
| ▸ | F2 | P00734 | 4/20 | 0.61 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.58 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.58 |
| ▸ | CXCL8 | P10145 | 2/20 | 0.57 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29416107 | 0.91 | GLP1R (0.69) | GLP1RCCKBRCALCRCXCR4 | |
| SCHEMBL30692441 | 0.90 | GLP1R (0.69) | GLP1RCCKBRCALCR | |
| SCHEMBL30530323 | 0.90 | GLP1R (0.69) | GLP1RCCKBRCALCR | |
| SCHEMBL29812659 | 0.90 | GLP1R (0.70) | GLP1RCCKBRCALCRF2HCRTR1 | |
| SCHEMBL29416123 | 0.89 | CXCR4 (0.60) | GLP1RCCKBRCALCRF2CXCL8 | |
| SCHEMBL29706295 | 0.88 | GLP1R (0.70) | GLP1RCCKBRCALCRF2 | |
| SCHEMBL31366365 | 0.87 | NMBR (0.61) | GLP1RCCKBRCALCRF2 | |
| SCHEMBL30504132 | 0.87 | F2 (0.62) | GLP1RCCKBRCALCRF2 | |
| SCHEMBL31182929 | 0.87 | CALCR (0.72) | GLP1RCCKBRCALCR | |
| SCHEMBL29416120 | 0.87 | GLP1R (0.58) | GLP1RCCKBRCALCRF2HCRTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109310732-B | Neurofilament peptides for preventing or slowing the progression of prostate cancer | 尼莫克斯股份有限公司 | 2023-07-21 | — | — | CN | disclosed |